SILVER STD RES INC's ticker is SSRI and the CUSIP is 82823L106. A total of 1 filers reported holding SILVER STD RES INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,176,000 | -8.4% | 429,900 | 0.0% | 0.05% | -4.0% |
| Q1 2017 | $4,560,000 | +70.5% | 429,900 | +43.3% | 0.05% | +61.3% |
| Q4 2016 | $2,675,000 | -11.7% | 299,900 | +19.3% | 0.03% | -8.8% |
| Q3 2016 | $3,029,000 | +4.3% | 251,400 | +12.3% | 0.03% | +6.2% |
| Q2 2016 | $2,904,000 | – | 223,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syntal Capital Partners, LLC | 17,540 | $167,000 | 0.12% |